OHSU Co-Founded Company, Autobahn Therapeutics, Attracts $100 Million Investment
July 30, 2024
July 30, 2024
PORTLAND, Oregon, July 30 (TNSres) -- Oregon Health and Science University issued the following news:
* * *
Massive investment advances treatment prospects for major depressive disorder, bipolar depression that affect tens of millions in U.S.
* * *
Autobahn Therapeutics -- a biotechnology company first established out of a lab at Oregon Health & Science University -- has generated a $100 million round of private investment to develop new tr . . .
* * *
Massive investment advances treatment prospects for major depressive disorder, bipolar depression that affect tens of millions in U.S.
* * *
Autobahn Therapeutics -- a biotechnology company first established out of a lab at Oregon Health & Science University -- has generated a $100 million round of private investment to develop new tr . . .